Comparison · NCT00906347-6ba0249a
Misoprostol Augmentation vs Oxytocin Augmentation: Maternal Chorioamnionitis
Calculated by ConductScience from the counts the trial posted to ClinicalTrials.gov.
2 sourcestrial-comparisons-2026-03-23-0.1.0
Cite this record
ConductScience Library. Misoprostol Augmentation vs Oxytocin Augmentation: Maternal Chorioamnionitis. Trial comparisons, record NCT00906347-6ba0249a. Release trial-comparisons-2026-03-23-0.1.0, 23 Mar 2026. https://conductscience.org/library/comparisons/NCT00906347-6ba0249a
On this page
Measures6
Calculated by ConductScience from the counts the trial posted to ClinicalTrials.gov.
| Measure | Value | 95% interval, lower | 95% interval, upper | Method | Note |
|---|---|---|---|---|---|
| Risk in group 1 | 0.159 | 0.112 | 0.22 | wilson | |
| Risk in group 2 | 0.184 | 0.133 | 0.248 | wilson | |
| Risk difference, group 1 minus group 2 | -0.0248 | -0.104 | 0.0546 | newcombe hybrid score | |
| Risk ratio, group 1 over group 2 | 0.865 | 0.545 | 1.37 | log | |
| Odds ratio, group 1 over group 2 | 0.84 | 0.481 | 1.47 | log | |
| Number needed to treat, for one fewer participant with the outcome on Misoprostol Augmentation than on Oxytocin Augmentation | 40.3 | from the risk difference interval | the interval includes no difference |
Source ClinicalTrials.gov
Groups2
Neither group, or both, names a comparator, so the groups keep ClinicalTrials.gov's order.
| Group | Title | Description | With the outcome | Analysed | ClinicalTrials.gov code |
|---|---|---|---|---|---|
| Group 1 | Misoprostol Augmentation | Women with hypotonic labor and a clinical decision to proceed with labor augmentation will receive oral misoprostol.~Misoprostol : 75 micrograms orally every 4 hours for up to 2 doses. | 28 | 176 | OG000 |
| Group 2 | Oxytocin Augmentation | Women with hypotonic labor and a clinical decision to proceed with labor augmentation will receive intravenous oxytocin.~Oxytocin : Intravenous oxytocin will be administered per the established Labor and Delivery protocol at Parkland Memorial Hospital | 32 | 174 | OG001 |
Source ClinicalTrials.gov
Outcome
- Type
- SECONDARY
- Title
- Maternal Chorioamnionitis
- Description
- Temperature 38 degrees C or higher in the absence of other sources of infection
- Time frame
- During labor
- Population
- Intent to treat
Source ClinicalTrials.gov
Trial
- Title
- A Trial of Oral Misoprostol for Labor Augmentation
- NCT number
- NCT00906347
- Phases
- PHASE4
- Conditions
- Labor Augmentation
- Interventions
- Misoprostol, Oxytocin
- Lead sponsor
- University of Texas Southwestern Medical Center
- Results first posted
- 2012-11-07
- Results on ClinicalTrials.gov
- https://clinicaltrials.gov/study/NCT00906347?tab=results
Source ClinicalTrials.gov
Source
- Release
- trial-comparisons-2026-03-23-0.1.0
- Release manifest SHA-256
- f66225897fbf258b57ea10bdacfd0347d3cdfda93f7f5685234b7e06ea36fa57
- AACT copy
- 2026-03-23
- Tables read
- outcome_counts.parquet, outcome_measurements.parquet, outcomes.parquet, reported_event_totals.parquet, reported_events.parquet, result_groups.parquet, studies.parquet, ctgov_trial.parquet
Source ClinicalTrials.gov
Sources 2
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions. The measures are ConductScience's calculation from them.
For software
Read this comparison from software.
The record is JSON. No key.
GET https://conductscience.org/api/comparisons/v1/NCT00906347-6ba0249a